Profile
| Metric | Value |
|---|---|
| Full Name | Humacyte, Inc. |
| Ticker | NASDAQ: HUMA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | humacyte.com |
| Employees | 218 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $1.03 | ||
| Price, 1D Change | +3.00% | |
| $193M | ||
| - | ||
| - | ||
| 2.28 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$1.26 | ||
| EPS, 1Y Change | -17.18% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | AHAC | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.26 | ||
| EPS Estimate | -$0.38 | |
| EPS Est. Change | +69.40% | |
| $0.00 | ||
| Revenue Estimate | $2.84M | |
| Revenue Est. Change | - | |
| $1.03 | ||
| Price Target | - | $3.50 |
| Price Tgt. Change | - | +239.81% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.06 | -$1.07 | -1.05% | |
| -$1.27 | -$1.26 | +1.17% | |
| -$0.38 | N/A | +69.40% | |
| -$0.53 | N/A | +58.09% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $60.00K | $0.00 | -100.00% | |
| $214.29K | $0.00 | -100.00% | |
| $2.84M | N/A | - | |
| $23.65M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -77.41% | ||
| -62.95% | ||
| -67.47% | ||
| -32.79% | ||
| 0.00% | ||
| 0.00% | ||
| -17.18% | ||
| -89.48% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $1.03 | ||
| $1.71 | ||
| SMA 200 vs Price | +66.42% | |
| $1.15 | ||
| SMA 50 vs Price | +11.37% | |
| 2.28 | ||
| $0.09 | ||
| 44.55 | ||
| 100.00% | ||
| 112.64% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$1.26 | ||
| -$7.19M | ||
| - | ||
| -$114.40M | ||
| - | ||
| -$148.70M | ||
| - | ||
| -$132.23M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -1.53 | ||
| 2.40 | ||
| 2.40 | ||
| -15.03 | ||
| - | ||
| -9.45 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 122.78 | ||
| -40.60 | ||
| -2.28 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$52.67M | ||
| $44.94M | ||
| $137.87M | ||
| $47.86M | ||
| $190.54M | ||
| $19.95M | ||
| $80.49M | ||
| $2.92M | ||
| $4.49M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $114.40M | ||
| $114.40M | ||
| $7.19M | ||
| $25.80M | ||
| $7.19M | ||
| $9.28M | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$98.12M | ||
| -$1.57M | ||
| $114.18M | ||
| $1.57M | ||
| -$99.69M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Benchmark | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| BTIG | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| Benchmark | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → |
Analyst sentiment
Institutional ownership
Screeners with HUMA
FAQ
What is the ticker symbol for Humacyte, Inc.?
The ticker symbol for Humacyte, Inc. is NASDAQ:HUMA
Does Humacyte, Inc. pay dividends?
No, Humacyte, Inc. does not pay dividends
What sector is Humacyte, Inc. in?
Humacyte, Inc. is in the Healthcare sector
What industry is Humacyte, Inc. in?
Humacyte, Inc. is in the Biotechnology industry
What country is Humacyte, Inc. based in?
Humacyte, Inc. is headquartered in United States
When did Humacyte, Inc. go public?
Humacyte, Inc. initial public offering (IPO) was on December 1, 2020
Is Humacyte, Inc. in the S&P 500?
No, Humacyte, Inc. is not included in the S&P 500 index
Is Humacyte, Inc. in the NASDAQ 100?
No, Humacyte, Inc. is not included in the NASDAQ 100 index
Is Humacyte, Inc. in the Dow Jones?
No, Humacyte, Inc. is not included in the Dow Jones index
When was Humacyte, Inc. last earnings report?
Humacyte, Inc.'s most recent earnings report was on November 12, 2025
When does Humacyte, Inc. report earnings?
The next expected earnings date for Humacyte, Inc. is March 27, 2026
Data Sources & References
- HUMA Official Website humacyte.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1818382/000181838225000132/0001818382-25-000132-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1818382/000181838225000034/0001818382-25-000034-index.htm
- HUMA Profile on Yahoo Finance finance.yahoo.com/quote/HUMA
- HUMA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/huma